000 | 01919 a2200625 4500 | ||
---|---|---|---|
005 | 20250515230651.0 | ||
264 | 0 | _c20101027 | |
008 | 201010s 0 0 eng d | ||
022 | _a1528-0020 | ||
024 | 7 |
_a10.1182/blood-2009-05-222471 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJiang, Xiaoyan | |
245 | 0 | 0 |
_aProperties of CD34+ CML stem/progenitor cells that correlate with different clinical responses to imatinib mesylate. _h[electronic resource] |
260 |
_bBlood _cSep 2010 |
||
300 |
_a2112-21 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAntigens, CD34 |
650 | 0 | 4 | _aBenzamides |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aDrug Resistance, Neoplasm |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImatinib Mesylate |
650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplastic Stem Cells _xdrug effects |
650 | 0 | 4 |
_aPiperazines _xpharmacology |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aPyrimidines _xpharmacology |
650 | 0 | 4 |
_aStem Cells _xdrug effects |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aForrest, Donna | |
700 | 1 | _aNicolini, Franck | |
700 | 1 | _aTurhan, Ali | |
700 | 1 | _aGuilhot, Joelle | |
700 | 1 | _aYip, Calvin | |
700 | 1 | _aHolyoake, Tessa | |
700 | 1 | _aJorgensen, Heather | |
700 | 1 | _aLambie, Karen | |
700 | 1 | _aSaw, Kyi Min | |
700 | 1 | _aPang, Emily | |
700 | 1 | _aVukovic, Ranko | |
700 | 1 | _aLehn, Paeta | |
700 | 1 | _aRingrose, Ashley | |
700 | 1 | _aYu, Miao | |
700 | 1 | _aBrinkman, Ryan R | |
700 | 1 | _aSmith, Clay | |
700 | 1 | _aEaves, Allen | |
700 | 1 | _aEaves, Connie | |
773 | 0 |
_tBlood _gvol. 116 _gno. 12 _gp. 2112-21 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2009-05-222471 _zAvailable from publisher's website |
999 |
_c19922360 _d19922360 |